Skip to content

Press

Portfolio-Media Coverage
New Eli Lilly-backed neurological disease biotech Nido unveils with $109M
May 15, 2023 May 15, 2023 Fierce Biotech
Portfolio-Media Coverage
Lilly-Backed Nido Biosciences Launches with $109M to Target Neurological Diseases
May 15, 2023 May 15, 2023 Biospace
Portfolio-Media Coverage
Startup Nido Bio Reveals $109M (so far) for Precision Approach to Neuro Disorder
May 15, 2023 May 15, 2023 MedCity News
Portfolio-Media Coverage
Nido Bio launches to develop small-molecule drugs for neurological diseases
May 15, 2023 May 15, 2023 Firstword Pharma
Portfolio-Media Coverage
Nido Biosciences Secures $109 Million to Advance Precision Medicines for Neurological Diseases
May 15, 2023 May 15, 2023 Silicon Valley Journals
Portfolio-Media Coverage
Nido Biosciences raises $109M to drug novel targets in neurological disease
May 15, 2023 May 15, 2023 Bioworld
Portfolio-Media Coverage
Nido Bio – Five years after founding, neuroscience startup emerges with $109M
May 15, 2023 May 15, 2023 BizJournals
Portfolio-Media Coverage
Nido debuts with $109M for its precision approach to brain drugs
May 15, 2023 May 15, 2023 Biopharma Dive
Portfolio-Media Coverage
From 5AM’s nest, neuroscience startup Nido Biosciences launches with $109M and PhI underway
May 15, 2023 May 15, 2023 Endpoints
Portfolio-Media Coverage
Ensoma – GENE EDITING: Overhyped or Unstoppable Tide?
May 9, 2023 May 9, 2023 Evaluate Vantage